Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net Income	$ 5,226	$ 4,724
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses	1,500	1,200
Depreciation and (accretion) amortization	(1,647)	294
Net amortization on securities	2,320	1,685
Increase in cash surrender value of bank owned life insurance	(478)	(141)
Amortization of core deposit intangible	93	154
Share based compensation expense	752	593
Net securities losses	10	1,128
Increase in accrued interest receivable	(2,157)	(777)
Increase in other assets	(7,123)	(5,811)
Increase in accrued expenses and other liabilities	2,830	4,820
Net cash provided by operating activities	1,326	7,869
Cash flows from investing activities:
Purchases of securities available for sale	(90,479)	(208,973)
Purchases of securities, restricted	(190,472)	(266,592)
Purchases of securities held to maturity	(10,175)	(30,936)
Proceeds from sales of securities available for sale	73,788	234,749
Redemption of securities, restricted	190,102	265,536
Maturities, calls and principal payments of securities available for sale	61,736	36,510
Maturities, calls and principal payments of securities held to maturity	10,392	26,763
Net increase in loans	(190,049)	(100,777)
Proceeds from loan sale	1,861
Proceeds from sales of other real estate owned, net		2,242
Purchase of premises and equipment	(2,668)	(2,321)
Net cash acquired in business combination	24,628	2,926
Net cash used in investing activities	(121,336)	(40,873)
Cash flows from financing activities:
Net increase in deposits	163,095	42,339
Net (decrease) increase in federal funds purchased	(5,000)	6,000
Net increase (decrease) increase in FHLB advances	1,500	9,000
Repayment of acquired unsecured debt		(1,450)
Net (decrease) increase in repurchase agreements	(9,690)	22
Net proceeds from issuance of common stock	349	310
Net proceeds from exercise of stock options	80	7
Repurchase of surrendered stock from vesting of restricted stock awards	(212)	(147)
Excess tax benefit from share based compensation	48	30
Cash dividends paid	(5,392)	(5,287)
Other, net	(303)	(192)
Net cash provided by financing activities	144,475	50,632
Net increase in cash and cash equivalents	24,465	17,628
Cash and cash equivalents at beginning of period	51,730	45,573
Cash and cash equivalents at end of period	76,195	63,201
Cash paid for:
Interest	3,707	3,656
Income tax	4,335	883
Noncash investing and financing activities:
Securities which settled in the subsequent period		5,372
Transfers from portfolio loans to OREO		577
Acquisition of noncash assets and liabilities:
Fair value of assets acquired	875,482	209,022
Fair value of liabilities assumed	$ 828,081	$ 213,224